跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NIAPELF 25 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
NIAPELF 25 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG
Approved
STANDARD
NIAPELF 25 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG
Neuraxpharm Pharmaceuticals S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 19, 2024
Approval ID
d506cd28aa7e539e
Company
Neuraxpharm Pharmaceuticals S.L.
Type
Standard
Approval Details
Approval Id
d506cd28aa7e539e
Drug Cima Aemps Name
NIAPELF 25 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG
Register Number
1241795001
Holder Company Name
Neuraxpharm Pharmaceuticals S.L.
Marketing Company Name
Neuraxpharm Spain S.L.
Holder Company Detail Path
/organization/neuraxpharm-pharmaceuticals-s-l
Authorization Date
2024-04-19
Dosage Form
SUSPENSION INYECTABLE DE LIBERACION PROLONGADA
Dose
25 mg
Route Of Administration
VÍA INTRAMUSCULAR
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Neuraxpharm Pharmaceuticals S.L.
Company Detail Path
/organization/neuraxpharm-pharmaceuticals-s-l
Company Information
Pharmaceutical Company Name
NEURAXPHARM PHARMACEUTICALS S.L.
Country Name
Spain
City Name
sant joan despi,barcelona,country_es
Address
AVENIDA BARCELONA 69
Active Ingredients
PALIPERIDONA PALMITATO
39 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 19, 2024
Approval ID
d506cd28aa7e539e
Type
Standard
Back to CIMA-AEMPS Approvals